Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 3, 1998, Pages 501-506

  Valicenti, Richard K ^a,b   Gomella, Leonard G ^a   Ismail, Mohammed ^a   Grant Mulholland, S ^a   Petersen, Robert O ^a   Corn, Benjamin W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Prostate cancer; Radiation dose; Radiation therapy; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HEMORRHAGIC CYSTITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DERMATITIS; RADIATION DOSE; RADIATION ENTEROPATHY;

AGED; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 0031724966     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00270-3     Document Type: Article

References (22)

1. Partin AW, Pearson JD, Landis PK, et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urol 1994; 43(5): 649-659.
2. Parker SL, Tong T, Bolden S, et al. Cancer Statistics, 1966. Atlanta, GA: American Cancer Society; 1996.
3. Lange PH, Ercole CJ, Lightner DJ, et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141: 873.
4. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907.
5. Lange PH, Lightner DJ, Medini E, et al. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 1990; 144: 927-933.
6. Lightner DJ, Lange PH, Reddy PK, et al. Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 1990; 144: 921-926.
7. Link P, Freiha FS, Stamey TA. Adjuvant radiation therapy in patients with detectable prostate-specific antigen following radical prostatectomy. J Urol 1991; 145: 532-534.
8. Schild SE, Wong WW, Grado GL, et al. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 1994; 69: 613-619.
9. Wu JJ, King SC, Montana GS, et al. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 1995; 32(2): 317-323.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-462.
11. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972; 135: 185-192.
12. Cox DR. Regression models and life tables. J Roy Stat Soc 1982; 34: 187.
13. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin 1998; 48(1): 6-30.
14. Partin AW, Kattan MW, Subong E, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997; 277: 1445-1451.
15. Anscher MS, Prosnitz LR. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 1987; 138: 1407-1412.
16. Freeman JA, Lieskovsky G, Cook DW, et al. Radical retro-public prostatectomy and postoperative adjuvant radiation for pathological Stage C (PCNO) prostate cancer from 1976 to 1989: Intermediate findings. J Urol 1993; 149: 1029-1034.
17. Schild SE, Wong WW, Grado GL, et al. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 1996; 34(3): 535-541.
18. Gibbons RP, Cole BS, Richardson RG, et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 1986; 135: 65-68.
19. Cadeddu JA, Partin AW, DeWeese TL, et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 1998; 159: 173-178.
20. Forman JD, Meetze K, Pontes E, et al. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 1997; 158: 1436-1440.
21. Valicenti RK, Gomella LG, Ismail M, et al. Pathologic seminal vesicle invasion following radical prostatectomy (pT3CN0): Effect of early adjuvant radiation therapy on biochemical control. Cancer 1998; 82: 1909-14.
22. D'Amico AV, Whittington R, Malkowicz SB, et al. Prostate-specific antigen failure despite pathologically organ confined and margin-negative prostate cancer: The basis for an adjuvant therapy trial. J Clin Oncol 1997; 15: 1465-1469.